99TH GENERAL ASSEMBLY
State of Illinois
2015 and 2016
SB1466

Introduced 2/20/2015, by Sen. Donne E. Trotter

SYNOPSIS AS INTRODUCED:
225 ILCS 85/19.1 new

Amends the Pharmacy Practice Act. Allows a licensed pharmacist to dispense an opioid antagonist in accordance with written, standardized procedures or protocols developed by the Department of Financial and Professional Regulation, in consultation with the Department of Public Health, if such procedures or protocols are filed at the pharmacist's place of practice and with the Board of Pharmacy before implementation. Requires the pharmacist to complete a training program approved by the Department of Human Services under the Drug Overdose Prevention Program authorized under Alcoholism and Other Drug Abuse and Dependency Act. Defines "opioid antagonist". Effective immediately.
LRB099 09990 AMC 30210 b
FISCAL NOTE ACT MAY APPLY

A BILL FOR

SB1466LRB099 09990 AMC 30210 b
1 AN ACT concerning regulation.
2 Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
4 Section 5. The Pharmacy Practice Act is amended by adding
5Section 19.1 as follows:
6 (225 ILCS 85/19.1 new)
7 Sec. 19.1. Dispensing opioid antagonists.
8 (a) Due to the recent rise in opioid-related deaths in
9Illinois and the existence of an opioid antagonist that can
10reverse the deadly effects of overdose, the General Assembly
11finds that in order to avoid further loss where possible, it is
12responsible to allow greater access of such an antidote to
13those populations at risk of overdose.
14 (b) Notwithstanding any general or special law to the
15contrary, a licensed pharmacist may dispense an opioid
16antagonist in accordance with written, standardized procedures
17or protocols developed by the Department, in consultation with
18the Department of Public Health, if such procedures or
19protocols are filed at the pharmacist's place of practice and
20with the Board before implementation.
21 (c) Before dispensing an opioid antagonist pursuant to this
22Section, a pharmacist shall complete a training program
23approved by the Department of Human Services under the Drug

SB1466- 2 -LRB099 09990 AMC 30210 b
1Overdose Prevention Program authorized under Section 5-23 of
2the Alcoholism and Other Drug Abuse and Dependency Act. The
3training program shall include, but not be limited to, proper
4documentation and quality assurance.
5 (d) For the purpose of this Section, "opioid antagonist"
6means a dose of naloxone hydrochloride or any other similarly
7acting and equally safe drug approved by the United States Food
8and Drug Administration.
9 Section 99. Effective date. This Act takes effect upon
10becoming law.